Results 151 to 160 of about 220,758 (314)
Performance of the MIMO PRCP-OFDM System with Orthogonal Cyclic-Shift Sequences [PDF]
Unlike the conventional Pseudo-Random Posfix (PRP) orthogonal frequency division multiplexing (OFDM) or PRP-OFDM approach, recently we proposed a new transceiver framework for OFDM system, named as the Pseudo Random Cyclic Postfix (PRCP)-OFDM, with ...
Chern, Shiunn-jang
core
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
Influence of Prebending Principle Rolling Bush on Chain Performance
The prebending principle is used to roll the bushing,the gap of the seam can be reduced to a minimum and the fluctuation range of dimension is reduced obviously.
Liu Yi +3 more
doaj
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Damage accumulation in high performance synthetic fibre ropes
This thesis presents the results of an investigation into the process of damage and failure in small diameter high performance synthetic fibre ropes namely Dyneema, Vectran and Technora ropes.
Koohgilani, Mehran
core
Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis +3 more
wiley +1 more source
Development of Simulation-Based Environment for Multi-Echelon Cyclic Planning and Optimization
This paper focuses on the development of simulation-based environment for multi-echelon cyclic planning and optimisation in the product maturity phase. It is based on integration of analytical and simulation techniques.
Merkurjeva, Gaļina, Napalkova, Liāna
core

